Pancreastatin-13481

Test info

  
Pancreastatin
  
13481
  
LAB13481
  
PANCREAS
  

Pancreastatin is a 49 amino acid peptide produced by degradation of Chromo-granin A.  It inhibits Chromogranin A and Parathyroid Hormone release.  Pancreastatin also inhibits release of Somatostatin upon glucose stimulation.  It may also control carbohydrate metabolism and hyperglycemia.  Although there are no compounds with significant structural homology with Pancreastatin, there are minor similarities to Gastrin and Anti-Diuretic Hormone.  Pancreastatin reduces the the early phase of Glucose induced Insulin release.  Suppression of Insulin release upon Glucose stimulation is a characteristic feature of Type II Diabetes.  Pancreastatin could play an important therapeutic role in the treatment of diabetes.  Pancreastatin also inhibits release of Somatostatin.  It may also control carbohydrate metabolism and hyperglycemia.

Specimen

  

Patient should not be on any medications that may influence Insulin levels, if possible, for at least 48 hours prior to collection.

  
Z preservative tube plasma
  
  
10 mL
  
1.0 mL
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times to prevent clotting

  
  1. Spin within two (2) hours of sample collection
  2. Transfer plasma to a Amber screw-cap polypropylene frozen transport tube/vial - 4mL (LabCorp), labelled as Z tube plasma
  3. Freeze
  

Frozen (strict) - 14 days

Performance

  
Inter Science Institute via LabCorp (819227): R-LC
  
Varies
  
14 days
  

Direct radioimmunoassay

Clinical and Interpretive info

  

Up to 135 pg/mL

Billing

  
83519
  
Result 49013-6

Tracking

  
04/10/2019
  
12/29/2023
  
12/21/2023